Baxter 5% Dextrose & 0.9% Sodium Chloride Injection USP 1000mL | JB1064

Product Description

Baxter 5% Dextrose & 0.9% Sodium Chloride Injection USP 1000mL | JB1064 is a sterile intravenous solution. It contains 5% dextrose and 0.9% sodium chloride. Baxter Canada lists this product in a 1000mL VIAFLEX PVC container.

This solution is part of Baxter's Dextrose and Sodium Chloride Injection portfolio. It is intended for appropriate intravenous use by qualified healthcare professionals.

The solution contains 50 g/L of dextrose monohydrate and 9 g/L of sodium chloride. Baxter's prescribing information lists sodium and chloride concentrations of approximately 154 mmol/L each. The listed osmolarity is approximately 560 mOsmol/L.

Key Features

• 5% Dextrose Injection
• 0.9% Sodium Chloride
• 1000mL volume
• VIAFLEX PVC container
• Sterile solution
• Nonpyrogenic formulation
• No bacteriostatic or antimicrobial agents
• No added buffers
• Approximately 560 mOsmol/L osmolarity
• Approximately 3.5–6.5 pH range

Product Specifications

Clinical Use

Baxter identifies this product within its large-volume parenteral portfolio. It is intended for appropriate intravenous fluid and electrolyte therapy.

Selection and administration should be based on the patient's clinical requirements. Healthcare professionals should follow the current product monograph and applicable clinical protocols.

Packaging

The Baxter JB1064 is supplied in a 1000mL VIAFLEX PVC container. Baxter Canada's catalog identifies JB1064 as the corresponding item number.

Product Description

Baxter 5% Dextrose & 0.9% Sodium Chloride Injection USP 1000mL | JB1064 is a sterile intravenous solution. It contains 5% dextrose and 0.9% sodium chloride. Baxter Canada lists this product in a 1000mL VIAFLEX PVC container.

This solution is part of Baxter's Dextrose and Sodium Chloride Injection portfolio. It is intended for appropriate intravenous use by qualified healthcare professionals.

The solution contains 50 g/L of dextrose monohydrate and 9 g/L of sodium chloride. Baxter's prescribing information lists sodium and chloride concentrations of approximately 154 mmol/L each. The listed osmolarity is approximately 560 mOsmol/L.

Key Features

• 5% Dextrose Injection
• 0.9% Sodium Chloride
• 1000mL volume
• VIAFLEX PVC container
• Sterile solution
• Nonpyrogenic formulation
• No bacteriostatic or antimicrobial agents
• No added buffers
• Approximately 560 mOsmol/L osmolarity
• Approximately 3.5–6.5 pH range

Product Specifications Baxter 5% Dextrose & 0.9% Sodium Chloride 

Clinical Use

Baxter identifies this product within its large-volume parenteral portfolio. It is intended for appropriate intravenous fluid and electrolyte therapy.

Selection and administration should be based on the patient's clinical requirements. Healthcare professionals should follow the current product monograph and applicable clinical protocols.

Visit EmerDepot for more medical supplies and healthcare produts in Canada